-
Adachi A, Gendelman H E, Koenig S. Production of acquired immunodeficiency syndrome-associated retrovirus in human and nonhuman cells transfected with an infectious molecular clone[J]. J Virol, 1986, 59(): 284-291.
-
Chen P, Flory E, Avots A. Transactivation of naturally occurring HIV-1 long terminal repeats by the JNK signaling pathway. The most frequent naturally occurring length polymorphism sequence introduces a novel binding site for AP-1 factors[J]. J Biol Chem, 2000, 275(): 20382-20390. doi: 10.1074/jbc.M001149200
-
Cohen P S, Schmidtmayerova H, Dennis J. The critical role of p38 MAP kinase in T cell HIV-1 replication[J]. Mol Med, 1993, 3(): 339-346.
-
Connor R I, Chen B K, Choe S. Vpr is required for efficient replication of human immunodefi-ciency virus type-1 in mononuclear phagocytes[J]. Virology, 1995, 206(): 935-944. doi: 10.1006/viro.1995.1016
-
Cuenda A and Rousseau S. p38 MAP-kinases pathway regulation, function and role in human diseases[J]. Biochim Biophys Acta, 2007, 1773(): 1358-1375. doi: 10.1016/j.bbamcr.2007.03.010
-
Davis R J. Signal transduction by the JNK group of MAP kinases[J]. Cell, 2000, 103(): 239-252. doi: 10.1016/S0092-8674(00)00116-1
-
DeFazio A, Chiew Y E, Sini R L. Expression of c-erbB receptors, heregulin and oestrogen receptor in human breast cell lines[J]. Int J Cancer, 2000, 87(): 487-498. doi: 10.1002/(ISSN)1097-0215
-
Fang JY and Richardson BC. The MAPK signalling pathways and colorectal cancer[J]. Lancet Oncol, 2005, 6(): 322-327. doi: 10.1016/S1470-2045(05)70168-6
-
Gibellini D, Re MC, Bassini A. HIV-1 gp120 induces the activation of both c-fos and c-jun immediate-early genes in HEL megakaryocytic cells[J]. Br J Haematol, 1999, 104(): 81-86. doi: 10.1046/j.1365-2141.1999.01141.x
-
Hommes D W, Peppelenbosch M P, van Deventer S J. Mitogen activated protein (MAP) kinase signal transduction pathways and novel anti-inflammatory targets[J]. Gut, 2003, 52(): 144-151. doi: 10.1136/gut.52.1.144
-
Jacque J M, Mann A, Enslen H. Modulation of HIV-1 infectivity by MAPK, a virion-associated kinase[J]. Embo J, 1998, 17(): 2607-2618. doi: 10.1093/emboj/17.9.2607
-
Ju S M, Song H Y, Lee J A. Extracellular HIV-1 Tat up-regulates expression of matrix metallo-proteinase-9 via a MAPK-NF-kappaB dependent pathway in human astrocytes[J]. Exp Mol Med, 2009, 41(): 86-93. doi: 10.3858/emm.2009.41.2.011
-
Junttila M R, Li S P, Westermarck J. Phosphatase-mediated crosstalk between MAPK signaling pathways in the regulation of cell survival[J]. Faseb J, 2008, 22(): 954-965.
-
Krens S F, Spaink H P, Snaar-Jagalska B E. Functions of the MAPK family in vertebrate-develop-ment[J]. FEBS Lett, 2006, 580(): 4984-4990. doi: 10.1016/j.febslet.2006.08.025
-
Mehrotra S, Chhabra A, Chattopadhyay S. Rescuing melanoma epitope-specific cytolytic T lymphocytes from activation-induced cell death, by SP600125, an inhibitor of JNK: implications in cancer immunotherapy[J]. J Immunol, 2004, 173(): 6017-6024. doi: 10.4049/jimmunol.173.10.6017
-
Muthumani K, Choo A Y, Shedlock D J. Human immunodeficiency virus type 1 Nef induces programmed death 1 expression through a p38 mitogen-activated protein kinase-dependent mechanism[J]. J Virol, 2008, 82(): 11536-11544. doi: 10.1128/JVI.00485-08
-
Pereira L A, Bentley K, Peeters A. A compilation of cellular transcription factor interactions with the HIV-1 LTR promoter[J]. Nucl Acids Res, 2000, 28(): 663-668. doi: 10.1093/nar/28.3.663
-
Popik W, Hesselgesser J E, Pitha P M. Binding of human immunodeficiency virus type 1 to CD4 and CXCR4 receptors differentially regulates expression of inflammatory genes and activates the MEK/ERK signaling pathway[J]. J Virol, 1998, 72(): 6406-6413.
-
Reiners J J, Jr Lee J Y, Clift R E. PD98059 is an equipotent antagonist of the aryl hydrocarbon receptor and inhibitor of mitogen-activated protein kinase kinase[J]. Mol Pharmacol, 1998, 53(): 438-445.
-
Toschi E, Bacigalupo I, Strippoli R. HIV-1 Tat regulates endothelial cell cycle progression via activation of the Ras/ERK MAPK signaling pathway[J]. Mol Biol Cell, 2006, 17(): 1985-1994. doi: 10.1091/mbc.E05-08-0717
-
Troppmair J, Bruder J T, Munoz H. Mitogen-activated protein kinase/extracellular signal-regulated protein kinase activation by oncogenes, serum, and 12-O-tetradecanoylphorbol-13-acetate requires Raf and is necessary for transformation[J]. J Biol Chem, 1994, 269(): 7030-7035.
-
Wainberg M A, Jeang K T. 25 years of HIV-1 research -progress and perspectives[J]. BMC Med, 2008, 6(): 31-. doi: 10.1186/1741-7015-6-31
-
Weston C R, Davis R J. The JNK signal transduction pathway[J]. Curr Opin Genet Dev, 2002, 12(): 14-21. doi: 10.1016/S0959-437X(01)00258-1
-
Weston C R, Davis R J. The JNK signal transduction pathway[J]. Curr Opin Cell Biol, 2007, 19(): 142-149. doi: 10.1016/j.ceb.2007.02.001
-
Yamamoto K, Ichijo H, Korsmeyer S J. BCL-2 is phosphorylated and inactivated by an ASK1/Jun N-terminal protein kinase pathway normally activated at G (2)/M[J]. Mol Cell Biol, 1999, 19(): 8469-8478. doi: 10.1128/MCB.19.12.8469
-
Yang X, Gabuzda D. Mitogen-activated protein kinase phosphorylates and regulates the HIV-1 Vif protein[J]. J Biol Chem, 1998, 273(): 29879-29887. doi: 10.1074/jbc.273.45.29879
-
Yang X, Chen Y, Gabuzda D. ERK MAP kinase links cytokine signals to activation of latent HIV-1 infection by stimulating a cooperative interaction of AP-1 and NF-kappaB[J]. J Biol Chem, 1999, 274(): 27981-27988. doi: 10.1074/jbc.274.39.27981